COMPARATIVE HUMAN ORAL CLINICAL PHARMACOLOGY OF CEFADROXIL, CEPHALEXIN, AND CEPHRADINE

被引：147

作者：

PFEFFER, M ^{[1
]}

JACKSON, A ^{[1
]}

XIMENES, J ^{[1
]}

PERCHEDEMENEZES, J ^{[1
]}

机构：

[1] BRISTOL MYERS CO INC,NEW YORK,NY 10022

来源：

关键词：

D O I：

10.1128/AAC.11.2.331

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：331 / 338

页数：8

共 10 条

[1] BUCK RD, 1976, ANTIMICROB AGENTS CH, V11, P324
[2] DIEM K, 1962, DOCUMENTA GEIGY, P545
[3] 2-PERIOD CHANGE-OVER DESIGN AND ITS USE IN CLINICAL TRIALS
GRIZZLE, JE
[J]. BIOMETRICS, 1965, 21 (02) : 467 - &
[4] AN ALGORITHM FOR LEAST-SQUARES ESTIMATION OF NONLINEAR PARAMETERS
MARQUARDT, DW
[J]. JOURNAL OF THE SOCIETY FOR INDUSTRIAL AND APPLIED MATHEMATICS, 1963, 11 (02): : 431 - 441
[5] SNEDECOR GW, 1973, STATISTICAL METHODS, P258
[6] Teorell T, 1937, ARCH INT PHARMACOD T, V57, P205
[7] NEWER CEPHALOSPORINS AND EXPANDED-SPECTRUM PENICILLINS
THRUPP, LD
[J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1974, 14 : 435 - 467
[8] OVERVIEW OF ANALYSIS AND INTERPRETATION OF BIOAVAILABILITY STUDIES IN MAN
WAGNER, JG
[J]. PHARMACOLOGY, 1972, 8 (1-3) : 102 - 117
[9] WAGNER JG, 1971, BIOPHARMACEUTICS REL, P247
[10] [No title captured]